Medrogestone produced in {HEAD ~ accordance} with {TAIL ~ the process} of this invention exhibits an HPLC strength in the order of 99.2% with total impurities at about 0.08% , thereby providing a very pure therapeutic agent 
Medrogestone produced in { HEAD ~ accordance } with { TAIL ~ the process } of this invention exhibits an HPLC strength in the order of 99.2 % with total impurities at about 0.08 % , thereby providing a very pure therapeutic agent
OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH